| Literature DB >> 23738232 |
Jip F Kamphuis1, Digna de Kam, Alexander C H Geurts, Vivian Weerdesteyn.
Abstract
Introduction. Improvement of postural stability is an important goal during poststroke rehabilitation. Since weight-bearing asymmetry (WBA) towards the nonparetic leg is common, training of weight-bearing symmetry has been a major focus in post-stroke balance rehabilitation. It is assumed that restoration of a more symmetrical weight distribution is associated with improved postural stability. Objective. To determine to what extent WBA is associated with postural instability in people after stroke. Methods. Electronic databases were searched (Cochrane, MEDLINE, EMBASE, and CINAHL) until March 2012. Main Eligibility Criteria. (1) Participants were people after stroke. (2) The association between WBA and postural stability was reported. Quality of reporting was assessed with the STROBE checklist and a related tool for reporting of confounding. Results. Nine observational studies met all criteria. Greater spontaneous WBA was associated with higher center of pressure (COP) velocity and with poorer synchronization of COP trajectories between the legs (two and one studies, resp.). Evidence for associations between WBA and performance on clinical balance tests or falls was weak. Conclusion. Greater WBA after stroke was associated with increased postural sway, but the current literature does not provide evidence for a causal relationship. Further studies should investigate whether reducing WBA would improve postural stability.Entities:
Year: 2013 PMID: 23738232 PMCID: PMC3655651 DOI: 10.1155/2013/692137
Source DB: PubMed Journal: Stroke Res Treat
Study characteristics.
| Author (year) | Study design | Number of participants with stroke | Participant characteristics | Baseline measures of stroke severity | Baseline measures of clinical balance | Category of balance measure | Dependent measures of postural stability | Statistics for association between WBA and postural stability |
|---|---|---|---|---|---|---|---|---|
| Van Asseldonk et al. (2006) [ | Cross-sectional |
| (1) 59.9 (8.3) | MI 51.5 (16.1) | FAC (4-5) | DP | Contribution of paretic leg to | ↑ |
|
| ||||||||
| Mansfield et al. (2011) [ | Cross-sectional |
| (1) 61 (14) | NIHSS 4.6 (4.1) | BBS 37.9 (15.6) | QS | COP amplitude synchronizationb |
|
|
| ||||||||
| Mansfield et al. (2012) [ | Cross-sectional |
| (1) 66.9 (14.9) | NIHSS 3.5 (3.0) | BBS 36.9 (14.6) | QS | COP amplitude synchronizationb
| ↑ |
|
| ||||||||
| Marigold et al. (2004) [ | Cross-sectional |
| (1) 61.3 (8.9) | Not reported | BBS 44.9 (8.3) | DP | TA amplitude | F2,18 = 1.51(p), 0.67(np)
|
|
| ||||||||
|
Marigold and Eng (2006) [ | Cross sectional |
| (1) 62.1 (8.6) | ChMcS-leg 4 (3-5) | BBS 46.2 | QS | COP amplitude (AP) | ↑ |
|
| ||||||||
| Pereira et al. (2010) [ | Cross-sectional |
| (1) 65 (10) | Not reported | Not reported | CB | Functional Reach | NS total group |
|
| ||||||||
| Peurala et al. (2007) [ | Cross-sectional |
| (1) Left hemi 53.4 (8) | FIM | FAC (2–5) | QS | COP velocity (AP) |
|
|
| ||||||||
| Roerdink et al. (2009) [ | Cross-sectional* |
| (1) 61.2 (13.0) | BFM | FAC 1–4 | QS | Sway aread | ↑ |
|
| ||||||||
| Sackley (1991) [ | Longitudinal cohort |
| (1) 63.3 (21–87) | Not reported | Not reported | FA | Number of falls | NS |
Values for descriptive data represent mean (sd) unless stated otherwise. Statistics represent R 2 as calculated from bivariate correlations unless stated otherwise. Significant associations are presented in bold. ↑: greater WBA is associated with more postural instability, ↓: greater WBA is associated with less postural instability AP: anteroposterior, BBS: Berg Balance Scale, BFM: Brunnstrom Fugl-Meyer assessment, CB: clinical balance test, ChMcS: Chedoke-McMaster Stroke assessment scores, COP: center of pressure, DP: dynamic posturography, FA: falls in daily life, FAC: Functional Ambulation Categories, FIM: Functional Independence Measure, FR: Functional Reach test, IQR: interquartile range, MG: medial gastrocnemius, MI: Motricity Index, ML: mediolateral, N: number of stroke participants, NIHSS: National Institutes of Health Stroke Scale, NP: non-paretic, NS: no significant association with WBA, p: paretic, QS: quiet standing posturography, TA: tibialis anterior, TBT: Timed Balance Test, TUG: Timed Up and Go test, WBA: weight-bearing asymmetry. *Longitudinal study, but correlations between WBA and postural control were analyzed cross-sectionally. a% contribution of the paretic leg to total amount of generated corrective torque. bCalculated by cross-correlating COP amplitude time series, cpower spectral density functions, dtotal area covered by the COP trajectory.
STROBE criteria scoring definitions.
| Part of study | Item | Score 1 if it | |
|---|---|---|---|
| Title and abstract | |||
|
| |||
| 1a | Indicate study design with a commonly used term in the title or in the abstract | (i) Mentions an explicit commonly used term for the study design in title or abstract | |
| 1b | Provide in the abstract an informative and balanced summary of what was done and what was found | (i) Includes a short description of the research question, methods, results, and conclusion | |
|
| |||
| Introduction | |||
|
| |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | (i) Provides important context, sets the stage for the study, and describes its focus |
|
| |||
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | (i) States all original objectives |
|
| |||
| Methods | |||
|
| |||
| Study design | 4 | Present key elements of study design early in the paper | (i) Presents study design including source population of both cases and controls point in time the sample was taken, and if applicable the follow-up period |
|
| |||
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, followup, and data collection | (i) Includes recruitment sites or sources |
|
| |||
| Participants | 6a | Cohort study—give the eligibility criteria and the sources and methods of selection of participants. Describe methods of followup | (i) Describes all eligibility criteria and also the group from which the population was selected |
| 6b | Cohort study—for matched studies, give matching criteria and number of exposed and unexposed | (i) Describes matching criteria, numbers of exposed and unexposed or numbers of controls per case | |
|
| |||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | (i) Defines all variables for and included in the analyses |
|
| |||
| Data sources/measurement | 8 | For each variable of interest give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | (i) Refers to studies that report validity or reliability of the outcome measure OR |
|
| |||
| Bias | 9 | Describe any efforts to address potential sources of bias | (i) Describes what measures were taken during the conduct of the study to reduce the potential of bias |
|
| |||
| Study size | 10 | Explain how the study size was arrived at | (i) Reports formal sample size calculations if they were done, or |
|
| |||
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen, and why | (i) For categorized variables, explains why and how data were grouped including the number of categories, the cut points, and category means or medians |
|
| |||
| Statistical methods | 12a | Describe all statistical methods, including those used to control for confounding | (i) Describes statistical methods to enable a reader with access to the data to verify the reported results |
| 12b | Describe any methods used to examine subgroups and interactions | (i) Describes what methods were used for subgroup analysis | |
| 12c | Explain how missing data were addressed | (i) If applicable, reports the number of missing values for each variable of interest and for each step in the analysis | |
| 12d | Cohort study—if applicable, explain how loss to followup was addressed | (i) Cohort: reports on the number of individuals that were lost to follow-up and how those data were treated in the analyses | |
| 12e | Describe any sensitivity analyses | (i) Describes sensitivity analyses, for example, used to identify the degree of confounding, selection bias, or information bias required to distort an association | |
|
| |||
| Results | |||
|
| |||
| Participants | 13a | Report the numbers of individuals at each stage of the study, for example, numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed | (i) Reports the number of individuals considered at each stage of the study from the stage of recruiting from the target population to the inclusion of participants' data in the analysis: numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing followup, and analyzed |
| 13b | Give reasons for nonparticipation at each stage | (i) If applicable, explains why participants no longer participated in the study or why they were excluded from further analysis | |
| 13c | Consider use of a flow diagram | (i) Especially for complex studies, not applicable for small cross-sectional studies | |
|
| |||
| Descriptive data | 14a | Give characteristics of study participants (e.g., demographic, clinical, and social) and information on exposures and potential confounders | (i) Presents data as follows: |
| 14b | Indicate the number of participants with missing data for each variable of interest | (i) Explicitly mentions the number of participants with missing data, OR | |
| 14c | Cohort study—summarize follow-up time (e.g., average and total amount) | ||
|
| |||
| Outcome data | 15 | Cohort study—report numbers of outcome events or summary measures over time | (i) Presents descriptive data for exposure and outcome measures separately and not only the association between the measures |
|
| |||
| 16a | Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included | (i) Gives unadjusted estimates of effect size | |
| Main results | 16b | Report category boundaries when continuous variables were categorized | (i) Reports category boundaries when continuous variables were categorized |
| 16c | If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | (i) Only for ratio measures | |
|
| |||
| Other analysis | 17 | Report other analyses done—for example, analyses of subgroups and interactions, and sensitivity analyses | (i) Describes whether these analyses were planned in advance and which arose while analyzing |
|
| |||
| Discussion | |||
|
| |||
| Key results | 18 | Summarize key results with reference to study objectives | (i) Begins the discussion with a short summary of the main findings of the study |
|
| |||
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | (i) Mentions |
|
| |||
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | (i) Interprets the results taking into consideration the limitations of the study or bias. |
|
| |||
| Generalizability | 21 | Discuss the generalizability (external validity) of the study results | (i) Gives sufficient information for the reader to judge the generalizability |
|
| |||
| Other information | |||
|
| |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | (i) Gives the source of funding |
Figure 1Flow chart of systematic review of weight-bearing asymmetry (WBA) related to postural control.
Reporting quality of individual studies according to the STROBE criteria.
| Van Asseldonk et al. (2006) [ | Mansfield et al. (2011) [ | Mansfield et al. (2012) [ | Marigold et al. (2004) [ | Marigold and Eng (2006) [ | Pereira et al. (2010) [ | Peurala et al. (2007) [ | Roerdink et al. (2009) [ | Sackley (1991) [ | Proportion of studies that satisfied criteria | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1a | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 2/9 (22%) | |
| 1b | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9/9 (100%) | |
| Background/rationale | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 8/9 (89%) |
| Objectives | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9/9 (100%) |
| Study design | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1* | 0 | 1/9 (11%) |
| Setting | 5 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1* | 1 | 5/9 (56%) |
| Participants | 6a | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1* | 1 | 6/9 (67%) |
| 6b | 1 | 0 | NA | 0 | 0 | NA | 0 | NA | NA | 1/5 (20%) | |
| Variables | 7 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9/9 (100%) |
| Data sources/measurement | 8 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8/9 (89%) |
| Bias | 9 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 4/9 (44%) |
| Study size | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0/9 (0%) |
| Quantitative variables | 11 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7/9 (78%) |
| Statistical methods | 12a | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9/9 (100%) |
| 12b | NA | NA | NA | NA | 1 | 1 | NA | 1 | NA | 3/3 (100%) | |
| 12c | 1 | 1 | 0 | NA | NA | NA | NA | 0 | 1 | 3/5 (60%) | |
| 12d | NA | NA | NA | NA | NA | NA | NA | 1* | 1 | 2/2 (100%) | |
| 12e | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0/9 (0%) | |
| Participants | 13a | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0/9 (0%) |
| 13b | NA | 1 | 0 | NA | NA | NA | NA | 0* | 1 | 2/4 (50%) | |
| 13c | NA | NA | NA | NA | NA | NA | NA | 0 | 0 | 0/2 (0%) | |
| Descriptive data | 14a | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1* | 1 | 8/9 (89%) |
| 14b | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 7/9 (78%) | |
| 14c | NA | NA | 0 | NA | NA | NA | NA | 1* | 1 | 2/3 (67%) | |
| Outcome data | 15 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9/9 (100%) |
| Main results | 16a | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8/9 (89%) |
| 16b | NA | NA | NA | NA | NA | NA | 1 | NA | NA | 1/1 (100%) | |
| 16c | NA | NA | 0 | NA | NA | NA | NA | NA | NA | 0/1 (0%) | |
| Other analysis | 17 | NA | NA | NA | NA | 1 | 0 | NA | 1 | 1 | 3/4 (75%) |
| Key results | 18 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 5/9 (56%) |
| Limitations | 19 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 6/9 (67%) |
| Interpretation | 20 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 6/9 (67%) |
| Generalizability | 21 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 5/9 (56%) |
| Funding | 22 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 3/9 (33%) |
|
| |||||||||||
| Total score | 17/26 | 18/27 | 19/28 | 14/25 | 16/27 | 14/26 | 14/26 | 22/31 | 17/30 | ||
|
| |||||||||||
| Percentage | 65% | 67% | 68% | 56% | 59% | 54% | 54% | 71% | 57% | ||
*Score is based on the original study of de Haart et al. 2004 [11].
Reporting of confounding bias in individual studies [23].
| Van Asseldonk et al. (2006) [ | Mansfield et al. (2011) [ | Mansfield et al. (2012) [ | Marigold et al. (2004) [ | Marigold and Eng (2006) [ | Pereira et al. (2010) [ | Peurala et al. (2007) [ | Roerdink et al. (2009) [ | Sackley (1991) [ | Number of studies satisfied criteria | |
|---|---|---|---|---|---|---|---|---|---|---|
| (1) Reporting of reasons why potential confounders are selected for analysis | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| (2) Reporting of reasons to include confounders in final model | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| (3) Reporting of characteristics of key confounders | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| (4) Any method used to control for confounding | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 3 |
| (5) Reporting of both crude and adjusted effect estimate | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| (6) Comment on likelihood of unobserved confounding | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 5 |
| (7) Reporting of a qualitative statement on the direction of the potential effect of unobserved confounding | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| (8) Sensitivity analysis used to estimate potential impact of unobserved confounding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| ||||||||||
| Total score | 1 | 0 | 7 | 1 | 4 | 1 | 0 | 1 | 1 | |